1,000
Participants
Start Date
November 1, 2019
Primary Completion Date
July 1, 2021
Study Completion Date
May 31, 2022
Invitae multi-cancer gene panel
Invitae's multi-cancer panel tests for 84 genes associated with hereditary cancer risk.
Perlmutter Cancer Center, NYU Langone Health, New York, New York
Associated Medical Professionals, Syracuse
MidLantic Urology, Bala-Cynwyd
Carolina Urologic Research Center, Myrtle Beach
North Georgia Urology, Dalton
Florida Urology Partners, Tampa
TGH Cancer Institute, Tampa
Advanced Urology Institute, St. Petersburg
Urology Associates, P.C., Nashville
Associated Urological Specialists, Chicago Ridge
Urology Partners, Arlington
Urosurgery Houston, Houston
Urology Austin, Austin
Colorado Urology, Lakewood
Genesis Healthcare Partners, San Diego
Invitae, San Francisco
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco
Volunteer Faculty, University of California San Francisco, San Francisco
University Urology Associates of New Jersey, Hamilton
Lead Sponsor
Invitae Corporation
INDUSTRY